News & Updates
Showing Obstetrics & Gynaecology articles
Showing

Higher dietary inflammation potential linked to polycystic ovary syndrome
Women who consume foods with greater inflammation potential in high amounts are more likely to have polycystic ovary syndrome (PCOS), a study has found.
Higher dietary inflammation potential linked to polycystic ovary syndrome
18 Apr 2022
Maintenance selinexor promising for PFS in advanced/recurrent endometrial cancer
Maintenance treatment with selinexor improved progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer who had previously received first-line chemotherapy, particularly those with endometrioid histology and wild-type p53, according to a study presented at SGO 2022.
Maintenance selinexor promising for PFS in advanced/recurrent endometrial cancer
14 Apr 2022
First-line niraparib maintenance regimen boosts PFS in advanced ovarian cancer
First-line maintenance therapy with niraparib at an individualized starting dose (ISD) improved progression-free survival (PFS) in patients with newly diagnosed advanced ovarian cancer, according to results of the phase III PRIME study presented at SGO 2022.
First-line niraparib maintenance regimen boosts PFS in advanced ovarian cancer
11 Apr 2022
SARS-CoV-2 tied to increased obstetric-related morbidity, mortality
SARS-CoV-2 infection during pregnancy or the postpartum period is tied to an increased risk of maternal mortality or serious morbidity due to obstetric complications, a study from the US showed.
SARS-CoV-2 tied to increased obstetric-related morbidity, mortality
08 Apr 2022
Mild chronic hypertension in pregnancy: BP-lowering treatment improves outcomes without harm
When it comes to treating mild chronic hypertension during pregnancy, a strategy of lowering blood pressure (BP) below 140/90 mm Hg is preferrable, as it leads to better pregnancy outcomes without increasing the risk of birthing small-for-gestational-age babies when compared with a strategy of reserving treatment only for severe hypertension, according to the open-label Chronic Hypertension and Pregnancy (CHAP) trial.




